boswellia AKBA
Selected indexed studies
- Boswellia serrata acts on cerebral edema in patients irradiated for brain tumors: a prospective, randomized, placebo-controlled, double-blind pilot trial. (Cancer, 2011) [PMID:21287538]
- Quantification of AKBA in Boswellia sacra Using NIRS Coupled with PLSR as an Alternative Method and Cross-Validation by HPLC. (Phytochem Anal, 2018) [PMID:28881407]
- Boswellia serrata extract with low 3O-acetyl-11-keto-β-boswellic acid-content causes efficient lipid mediator class switch. (Phytomedicine, 2025) [PMID:41075523]
_Worker-drafted node — pending editorial review._
Connections
boswellia AKBA protects against
boswellia AKBA helps
Sources
- Enhanced Neuroprotection of Acetyl-11-Keto-β-Boswellic Acid (AKBA)-Loaded O-Carboxymethyl Chitosan Nanoparticles Through Antioxidant and Anti-Inflammatory Pathways. (2016) pubmed
- Safety and Toxicological Evaluation of a Novel, Standardized 3-O-Acetyl-11-keto-beta-Boswellic Acid (AKBA)-Enriched Boswellia serrata Extract (5-Loxin(R)). (2006) pubmed
- Boswellia serrata acts on cerebral edema in patients irradiated for brain tumors: a prospective, randomized, placebo-controlled, double-blind pilot trial. (2011) pubmed
- Quantification of AKBA in Boswellia sacra Using NIRS Coupled with PLSR as an Alternative Method and Cross-Validation by HPLC. (2018) pubmed
- Boswellia serrata extract with low 3O-acetyl-11-keto-β-boswellic acid-content causes efficient lipid mediator class switch. (2025) pubmed
- Quantitative Determination of 3-O-Acetyl-11-Keto-βBoswellic Acid (AKBA) and Other Boswellic Acids in Boswellia sacra Flueck (syn. B. carteri Birdw) and Boswellia serrata Roxb. (2016) pubmed
- The Biological Activity of 3-O-Acetyl-11-keto-β-Boswellic Acid in Nervous System Diseases. (2022) pubmed
- Loading AKBA on surface of silver nanoparticles to improve their sedative-hypnotic and anti-inflammatory efficacies. (2019) pubmed
- Permeation of Boswellia extract in the Caco-2 model and possible interactions of its constituents KBA and AKBA with OATP1B3 and MRP2. (2009) pubmed
- Sublingual AKBA Exerts Antidepressant Effects in the Aβ-Treated Mouse Model. (2021) pubmed